An observational study conducted by researchers at the University of Texas MD Anderson Cancer Center and the University of Florida (UF), the lead site of the OneFlorida+ PCORnet® Clinical Research Network, showed promising results for the potential of mRNA vaccines to improve health outcomes for people who have advanced lung or skin cancer.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Elizabeth Shenkman, Ph.D. Following a public workshop in July 2024, a report from the National Academies of Sciences, Engineering, and Medicine shares strategies for improving cancer surveillance. One of the OneFlorida+ Clinical Research Network’s executive chairs, Elizabeth Shenkman, Ph.D., spoke at the workshop about “Data Linkages in Cancer Surveillance…
